4BC5
Crystal structure of human D-xylulokinase in complex with inhibitor 5- deoxy-5-fluoro-D-xylulose
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2010-04-22 |
Detector | ADSC QUANTUM 315r |
Spacegroup name | P 32 |
Unit cell lengths | 102.109, 102.109, 159.101 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 28.980 - 1.980 |
R-factor | 0.1727 |
Rwork | 0.172 |
R-free | 0.19240 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | HUMAN D-XYLULOKINASE DETERMINED BY TWO- ENERGY SELENIUM MAD |
RMSD bond length | 0.010 |
RMSD bond angle | 1.060 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | BUSTER (2.11.1) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 33.960 | 2.010 |
High resolution limit [Å] | 1.980 | 1.980 |
Rmerge | 0.130 | 1.450 |
Number of reflections | 129196 | |
<I/σ(I)> | 6.9 | 0.7 |
Completeness [%] | 99.9 | 99 |
Redundancy | 5.3 | 3.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 200 MM MES/KOH PH 5.9, 13% PEG 6000 |